At the December joint meeting, the ADDF Boards of Governors and Overseers welcomed seven new members.
On Monday, November 9, Margaret and Daniel Loeb received The Charles Evans Award from the ADDF at our Sixth Annual Fall Symposium & Luncheon. Thanks to the generosity of our donors, the Symposium & Luncheon raised more than $1 million, the most in the event’s history.
AlzeCure Foundation announced today that it has been awarded a grant from the ADDF to support the further development of its small molecule neurorestorative project.
Dr. Longo’s pioneering approach may soon lead to new disease modifying drugs.
The Foundation for Mitochondrial Medicine (FMM) is hosting its Hope Flies Health Series Webinar: Research Connecting Alzheimer’s and Mitochondrial Disease on Wednesday, September 23, 2015. The Foundation developed the webinar with partners including the ADDF, MitoAction and Sharecare to particularly bring greater awareness to mitochondrial disease in conjunction with Global Mitochondrial Disease Awareness Week.
Collaboration advances development of therapeutics for the treatment of Alzheimer’s Disease.
The ADDF will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year.
Melvin R. Goodes Prize supports innovative projects by top researchers while honoring pioneering legacy of former Warner-Lambert CEO.
Carmel Valley's newest winery, Jarman Wines, will introduce two premium varietals to benefit the Alzheimer's Drug Discovery Foundation (ADDF) and to honor the matriarch of the family whose name graces the wines created for her.
Cleveland Clinic Lou Ruvo Center for Brain Health is now recruiting participants for a new, multicenter Alzheimer’s disease (AD) treatment trial, Rasagiline Rescue (R2), which is designed to determine if treatment with rasagiline is associated with improved brain glucose metabolism and improvement in memory.